Trial Profile
KRP-104 Phase 2 Dose Finding Study -Investigation on Type2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs KRP 104 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Kyorin Pharmaceutical
- 24 May 2016 New trial record